Skip to main content
SpringerLink
Log in
Book cover

Molecular Genetic Pathology pp 209–229Cite as

Clinical Genomics in Oncology

  • Chapter

  • 2108 Accesses

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   149.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Suggested Reading

Application in Diagnostics of Clinical Oncology

  • Nevins JR, Huang ES, Dressman H, et al. Towards integrated clinicogenomic models for personalized medicine: combining gene expression signatures and clinical factors in breast cancer outcomes prediction. Hum Mol Genet. 2003;12:R153–R157.

    Article  CAS  PubMed  Google Scholar 

  • Quackenbush J. Microarray analysis and tumor classification. N Engl J Med. 2006;354:2463–2472.

    Article  CAS  PubMed  Google Scholar 

  • Ramaswamy S, Golub TR. DNA microarrays in clinical oncology. J Clin Oncol. 2002;20:1932–1941.

    CAS  PubMed  Google Scholar 

  • Rebbeck TR. Inherited genetic markers and cancer outcomes: personalized medicine in the postgenome era. J Clin Oncol. 2006;24:1972–1974.

    Article  CAS  PubMed  Google Scholar 

Clinical Genomics in Breast Cancer

  • Chang JC, Hilsenbeck SG, Fuqua SA. The promise of microarrays in the management and treatment of breast cancer. Breast Cancer Res. 2005;7:100–104.

    Article  CAS  PubMed  Google Scholar 

  • Cronin M, Pho M, Dutta D, et al. Measurement of gene expression in archival paraffin-embedded tissues: development and performance of a 92-gene reverse transcriptase-polymerase chain reaction assay. Am J Pathol. 2004;164:35–42.

    CAS  PubMed  Google Scholar 

  • Lonning PE, Sorlie T, Borresen-Dale AL. Genomics in breast cancertherapeutic implications. Nat Clin Pract Oncol. 2005;2:26–33.

    Article  CAS  PubMed  Google Scholar 

  • Paik S, Shak S, Tang G, et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med. 2004;351:2817–2826.

    Article  CAS  PubMed  Google Scholar 

  • Pawitan Y, Bjohle J, Amler L, et al. Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts. Breast Cancer Res. 2005;7:R953–R964.

    Article  CAS  PubMed  Google Scholar 

  • Reis-Filho JS, Westbury C, Pierga JY. The impact of expression profiling on prognostic and predictive testing in breast cancer. J Clin Pathol. 2006;59:225–231.

    Article  CAS  PubMed  Google Scholar 

  • Wang Y, Klijn JG, Zhang Y, et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 2005;365:671–679.

    CAS  PubMed  Google Scholar 

Clinical Genomics in Carcinoma of Unknown Primary

  • Bloom G, Yang IV, Boulware D, et al. Multi-platform, multi-site, microarray-based human tumor classification. Am J Pathol. 2004;164:9–16.

    CAS  PubMed  Google Scholar 

  • Buckhaults P, Zhang Z, Chen YC, et al. Identifying tumor origin using a gene expression-based classification map. Cancer Res. 2003;63:4144–4149.

    CAS  PubMed  Google Scholar 

  • Dennis J, Hvidsten T, Wit E, et al. Markers of adenocarcinoma characteristic of the site of origin: development of a diagnostic algorithm. Clin Cancer Res. 2005;11:3766–3772.

    Article  CAS  PubMed  Google Scholar 

  • Dennis JL, Vass JK, Wit EC, et al. Identification from public data of molecular markers of adenocarcinoma characteristic of the site of origin. Cancer Res. 2002;62:5999–6005.

    CAS  PubMed  Google Scholar 

  • Lu J, Getz G, Miska E, et al. MicroRNA expression profiles classify human cancers. Nature 2005;435:834–838.

    Article  CAS  PubMed  Google Scholar 

  • Ma XJ, Patel R, Wang X, et al. Molecular classification of human cancers using a 92-gene real-time quantitative polymerase chain reaction assay. Arch Pathol Lab Med. 2006;130:465–473.

    CAS  PubMed  Google Scholar 

  • Pavlidis N, Fizazi K. Cancer of unknown primary (CUP). Crit Rev Oncol Hematol. 2005;54:243–250.

    Article  PubMed  Google Scholar 

  • Ramaswamy S, Tamayo P, Rifkin R, et al. Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natl Acad Sci USA 2001;98:15, 149–15, 154.

    Google Scholar 

  • Tothill RW, Kowalczyk A, Rischin D, et al. An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin. Cancer Res. 2005;65:4031–4040.

    Article  CAS  PubMed  Google Scholar 

  • Varadhachary GR, Abbruzzese JL, Lenzi R. Diagnostic strategies for unknown primary cancer. Cancer 2004;100:1776–1785.

    Article  CAS  PubMed  Google Scholar 

Clinical Genomics in Gastrointestinal Tumors

  • Eschrich S, Yang I, Bloom G, et al. Molecular staging for survival prediction of colorectal cancer patients. J Clin Oncol. 2005;23:3526–3535.

    Article  CAS  PubMed  Google Scholar 

  • Kan T, Shimada Y, Sato F, et al. Prediction of lymph node metastasis with use of artificial neural networks based on gene expression profiles in esophageal squamous cell carcinoma. Ann Surg Oncol. 2004;11: 1070–1078.

    Article  PubMed  Google Scholar 

  • Tamoto E, Tada M, Murakawa K, et al. Gene-expression profile changes correlated with tumor progression and lymph node metastasis in esophageal cancer. Clin Cancer Res. 2004;10;3629–3638.

    Article  CAS  PubMed  Google Scholar 

Clinical Genomics in Haematologic Malignancies

  • Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000;403:503–511.

    Article  CAS  PubMed  Google Scholar 

  • Armstrong SA, Kung AL, Mabon ME, et al. Inhibition of FLT3 in MLL. Validation of a therapeutic target identified by gene expression based classification. Cancer Cell 2003;3:173–183.

    Article  CAS  PubMed  Google Scholar 

  • Ebert BL, Golub TR. Genomic approaches to hematologic malignancies. Blood 2004;104:923–932.

    Article  CAS  PubMed  Google Scholar 

  • Lossos IS, Alizadeh AA, Rajapaksa R, et al. HGAL is a novel interleukin-4-inducible gene that strongly predicts survival in diffuse large B-cell lymphoma. Blood 2003;101:433–440.

    Article  CAS  PubMed  Google Scholar 

  • Lossos IS, Jones CD, Warnke R, et al. Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma. Blood 2001;98:945–951.

    Article  CAS  PubMed  Google Scholar 

  • Ross ME, Zhou X, Song G, et al. Classification of pediatric acute lymphoblastic leukemia by gene expression profiling. Blood 2003;102:2951–2959.

    Article  CAS  PubMed  Google Scholar 

  • Yeoh EJ, Ross ME, Shurtleff SA, et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 2002;1:133–143.

    Article  CAS  PubMed  Google Scholar 

Clinical Genomics in Prostate Cancer

  • Lapointe J, Li C, Higgins JP, et al. Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proc Natl Acad Sci USA 2004;101:811–816.

    Article  CAS  PubMed  Google Scholar 

  • Yu YP, Landsittel D, Jing L, et al. Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy. J Clin Oncol. 2004;22:2790–2799.

    Article  CAS  PubMed  Google Scholar 

Decision Tree Models

  • Chang HY, Nuyten DSA, Sneddon JB, et al. From the cover: robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. PNAS 2005;102:3738–3743.

    Article  CAS  PubMed  Google Scholar 

“Functional” Gene Expression Signatures

  • Chang HY, Sneddon JB, Alizadeh AA, et al. Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds. PLoS Biol. 2004;2:E7.

    Article  PubMed  Google Scholar 

Hierarchical Unsupervised Classification

  • Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumors. Nature 2000;406:747–752.

    Article  CAS  PubMed  Google Scholar 

  • Sorlie T, Perou C, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. PNAS 2001;98:10,869–10,874.

    Article  CAS  PubMed  Google Scholar 

  • Sotiriou C, Neo SY, McShane LM, et al. Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci USA 2003;100:10,393–10,398.

    Article  CAS  PubMed  Google Scholar 

Interpretation of Gene Lists

  • Bild AH, Yao G, Chang JT, et al. Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 2006;439:353–357.

    Article  CAS  PubMed  Google Scholar 

  • Segal E, Shapira M, Regev A, et al. Module networks: identifying regulatory modules and their condition-specific regulators from gene expression data. Nat Genet. 2003;34:166–176.

    Article  CAS  PubMed  Google Scholar 

  • Slonim DK. From patterns to pathways: gene expression data analysis comes of age. Nat Genet. 2002;Suppl 32:502–508.

    Google Scholar 

  • Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005;102:15,545–15,550.

    Article  CAS  PubMed  Google Scholar 

Points of Attention in the Design of Microarray Experiments

  • Abdullah-Sayani A, Bueno-de-Mesquita JM, van de Vijver MJ. Technology Insight: tuning into the genetic orchestra using microarrays—limitations of DNA microarrays in clinical practice. Nat Clin Pract Oncol. 2006;3:501–516.

    Article  CAS  PubMed  Google Scholar 

  • Chuaqui RF, Bonner RF, Best CJ, et al. Post-analysis follow-up and validation of microarray experiments. Nat Genet. 2002;32 Suppl:509–514.

    Google Scholar 

  • Tinker AV, Boussioutas A, Bowtell DD. The challenges of gene expression microarrays for the study of human cancer. Cancer Cell 2006;9:333–339.

    Article  CAS  PubMed  Google Scholar 

Statistical Analysis

  • Eisen M, Spellman P, Brown P, et al. Cluster analysis and display of genome-wide expression patterns. PNAS 1998;95:14,863–14,868.

    Article  CAS  PubMed  Google Scholar 

  • Statnikov A, Aliferis CF, Tsamardinos I, et al. A comprehensive evaluation of multicategory classification methods for microarray gene expression cancer diagnosis. Bioinformatics 2005;21:631–643.

    Article  CAS  PubMed  Google Scholar 

Supervised Classification (Knowledge Driven)

  • van de Vijver MJ, He YD, van’t Veer LJ, et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med. 2002;347:1999–2009.

    Article  PubMed  Google Scholar 

  • van’t Veer LJ, Dai H, van de Vijver MJ, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002;415:530–536.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands

    Hugo M. Horlings MD & Marc Van de Vijver MD, PhD (Professor of Pathology)

Authors
  1. Hugo M. Horlings MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marc Van de Vijver MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Pathology and Laboratory Medicine and Clarian Pathology Laboratory, Indiana University School of Medicine, Indianapolis, IN

    Liang Cheng MD (Professor of Pathology and Urology, Director of Molecular Pathology Laboratory, Chief of Genitourinary Pathology Division) (Professor of Pathology and Urology, Director of Molecular Pathology Laboratory, Chief of Genitourinary Pathology Division)

  2. Department of Pathology, Mount Sinai School of Medicine, New York, NY

    David Y. Zhang MD, PhD, MPH (Associate Professor of Pathology Director, Molecular Pathology Laboratory) (Associate Professor of Pathology Director, Molecular Pathology Laboratory)

  3. Mount Sinai Medical Center, New York, NY

    David Y. Zhang MD, PhD, MPH (Associate Professor of Pathology Director, Molecular Pathology Laboratory) (Associate Professor of Pathology Director, Molecular Pathology Laboratory)

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Humana Press, a part of Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Horlings, H.M., Van de Vijver, M. (2008). Clinical Genomics in Oncology. In: Cheng, L., Zhang, D.Y. (eds) Molecular Genetic Pathology. Humana Press. https://doi.org/10.1007/978-1-59745-405-6_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-405-6_8

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-974-1

  • Online ISBN: 978-1-59745-405-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation